Safety study of JANX011 in healthy adults
This trial tests a new drug called JANX011 in healthy adults to see if it is safe and well tolerated. It is a first step before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh between 110 and 265 pounds (50–120 kg) and your BMI is between 18 and 32.
- You are generally healthy, as determined by a doctor and lab tests.
- You have not had major surgery with general anesthesia in the last 12 weeks.
- You are not positive for hepatitis B, C, HIV, or tuberculosis.
- You have not taken any other experimental drug or device in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
This study tests a new oral drug called JX2105 in healthy people to see how safe it is and how the body handles it. It is a first-in-human phase 1 trial, so participants will help find the right dose and check for any side effects.
This trial is testing a new investigational drug called JH013 in healthy volunteers. It’s a first-in-human study to see how the drug is processed by the body and to check for safety.
This is a first-in-human safety study testing a new experimental immune therapy called JST-018. Researchers want to see how safe it is, how well your body tolerates it, and how your body processes it when given as an injection.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests whether a single dose of the drug JMKX001899 affects the heart's electrical activity (QTc interval) in healthy adults. It helps researchers understand the drug's safety before moving to larger studies.
Hear when a new Autoimmune trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.